Blog - Page 3624 of 5613

ThursdaySep 23, 2010 8:41 am

iTech Medical Inc. (IMSU.OB) Achieves ISO Certification

Located in Huntington Beach, California, iTech Medical is engaged in the research and commercial development of healthcare information systems. Today, iTech Medical reached a major milestone with the announcement they have received ISO 13485:2003 certification. The ISO 13485:2003 certification received is for the production and sale of surface electromyography (sEMG) diagnostic services for clinical use. This quality standard is globally recognized as the international standard for quality management systems specific to the design, development and production of medical devices. Leading the team at iTech is Wayne Cockburn who serves as the company’s President and CEO. Commenting on the ISO certification,…

ThursdaySep 23, 2010 8:34 am

Cono Italiano, Inc. (CNOZ.OB) Announces Strategic Partnership with TurboChef

Cono Italiano, Inc. announced yesterday a strategic partnership with TurboChef, the leading manufacturer of high efficiency ovens. Cono Italiano is the exclusive license holder for the North American Distribution and Manufacturing rights for "pizza cono." The pizza cono is a one-of-a-kind, drip-free, cone shaped pizza made from proprietary dough. Cono Italiano and the Executive Chefs of TurboChef, under the partnership, rigorously tested and developed the ideal Turbo Oven settings for the "pizza cones" as well as cones prepared with cheese steak, tacos, chicken parmigiana and egg and cheese. The settings will undergo pre-programming in the Tornado Oven to perfectly cook…

ThursdaySep 23, 2010 8:16 am

Neptune Technologies (NEPT) Reports Positive Preclinical Results for Leading Drug Candidate CaPre

Neptune Technologies & Bioressources Inc. is a leading innovator of science-based and clinically proven novel products for the nutraceutical and pharmaceutical markets. The company’s subsidiary, Acasti Pharma Inc., focuses primarily on treatments for chronic cardiovascular conditions within the over-the-counter, medical food and prescription drug markets. Acasti yesterday announced preclinical results demonstrating that its leading drug candidate CaPre™ outperformed the currently marketed Lovaza® by increasing HS-Omega-3 Index®. Lovaza is the only FDA-approved prescription fish oil solely indicated for the treatment of severe hypertriglyceridemia, a case of high glycerides, which can also lead to pancreatitis. The HS-Omega-3 Index measures an emerging risk…

WednesdaySep 22, 2010 3:05 pm

Intelligent Communication Enterprise Corp. (ICMC.OB) Launches Innovative and Unique Celebrity-focused Social Media Platform Modizo.com

Intelligent Communication Enterprise Corp., www.icecorpasia.com – a leading innovator in the mobile phone space with sophisticated enterprise/consumer solutions, introduced Modizo™ today during a huge, celebrity-studded event at the Grand Hyatt Hong Kong. The new online platform offers a unique and unprecedented level of connectivity between celebrities and their fan base via mobile messaging and exclusive spontaneous interactive video content. Editor-in-Chief of Modizo, Victor Jeffery, was the keynote speaker at this gala event and noted how Modizo is the brainchild of the Company’s founder. Envisioned as a fun and intuitive bridge between celebrities and their millions of fans all over the…

WednesdaySep 22, 2010 3:02 pm

Strategic American Oil Corp. (SGCA) Strengthens its Position in the Oil-Rich Illinois Basin

Strategic American Oil, www.strategicamericanoil.com – the oil and gas exploration and production firm with primary operations in Texas, Louisiana and Illinois, reported on efforts to extend and consolidate its footprint in Illinois today. The report highlights part of an overarching agenda by the Company, typified by the Waterflood #1 (WF1) prospect, to instantiate a diverse resource recovery program in the Illinois Basin. Waterflooding has proven efficacious and leads to great success for dozens of public and private companies, and SGCA has extensive knowledge of the technology, which has seen widespread use for over half a century, with almost all the…

WednesdaySep 22, 2010 3:01 pm

Pioneer Behavioral Health (PHC) Reports Strong Fourth Quarter

Pioneer Behavioral Health reported a strong year over year increase in sales in the fourth quarter of fiscal 2010 as the company continues its recovery from the recession of 2009. The company also reported a profit compared to a loss in the same period a year earlier. Pioneer Behavioral Health reported net sales of $14 million in the quarter ending 6/30/2010, compared to $11.7 million in the fourth quarter of fiscal 2009. The company attributed the large gain to increased occupancy at the Seven Hills Behavioral Institute, the Detroit Behavioral Institute and Harbor Oaks Hospital. Pioneer Behavioral Health reported net…

WednesdaySep 22, 2010 2:02 pm

Greenlight Resources Inc. (PRZCF) Provides Update on Lithium Project in Canada

Greenlight Resources Inc. issued an update on the development program at its properties in Canada, where the company is conducting phase one testing of the mineral potential of the area. Greenlight Resources Inc. has interests in the Brazil Lake Lithium and Rare Metal property located north of Yarmouth, Nova Scotia. The company has drilled a total of fourteen cored holes in order to assess the mineral component of its property. The total core sample length obtained to date is 1,829 meters with another 400 meters left in phase one. Greenlight Resources Inc. is looking for lithium deposits of sufficient size…

WednesdaySep 22, 2010 2:00 pm

RXi Pharmaceuticals Corp. (RXII) Partners with EyeGate to Advance Ocular Treatment Technology

RXi Pharmaceuticals Corp. has developed a comprehensive therapeutic platform based on RNA interference (RNAi) therapeutics to treat a number of diseases, scarring and retinal disorders. The company today announced its partnership with EyeGate Pharma, a leader in non-invasive ocular drug delivery, to collaborate on the ocular delivery of RNAi therapeutics. Per the agreement, both companies will contribute technology, expertise, and resources to develop ocular treatments. "The development of RNAi therapeutics to treat retinal disorders is a key focus for our company, and we are excited to be collaborating with EyeGate to explore new, patient friendly approaches for delivering RNAi therapeutics…

WednesdaySep 22, 2010 11:30 am

Curaxis Pharmaceutical Corp. (CURX.OB) Enters Into Equity Line Agreement with Southridge Partners

Curaxis Pharmaceutical Corp. is an emerging specialty pharmaceutical company with a hormone drug product candidate for the treatment of Alzheimer's disease and also multiple cancers. The company's therapeutic platform is based on the hypothesis that many diseases of aging may be caused by age-related changes in the function of a hormonal endocrine feedback loop that controls development, reproduction and aging in animals. The premise is that hormones associated with the feedback loop are beneficial early in life when they promote growth and development, but are harmful later in life when the mechanism for feedback is compromised. Curaxis announced today that…

WednesdaySep 22, 2010 11:28 am

Protectus Medical Devices, Inc. (PTMD.PK) Obtains U.S. Patent for Self-Sheathing Safety Syringe

Protectus Medical Devices, Inc. is proving to be a company on the move. Located in Minneapolis, Minnesota, Protectus, formerly known as E-18 Corp., operates through its wholly-owned subsidiary SquareOne Medical which develops and markets innovative safety medical devices that have the potential to drastically reduce needlestick injuries for medical professionals across the globe. Today, Protectus Medical took a major step towards prominence with the announcement they have received a U.S. Patent for its self-sheathing safety syringe. The patent which was granted by the U.S. Patent and Trademark Office is No. 7,799,002. This patent will provide 20 years of patent protection…

Site Search

Company Search